This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Eisai Croissance future
Future contrôle des critères 4/6
Informations clés
25.1%
Taux de croissance des bénéfices
25.6%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices | 19.6% |
Taux de croissance des recettes | 9.1% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Good |
Dernière mise à jour | 28 Feb 2023 |
Mises à jour récentes de la croissance future
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
3/31/2025 | 846,893 | 74,892 | 72,454 | 94,043 | 12 |
3/31/2024 | 770,224 | 51,301 | 58,492 | 84,345 | 13 |
3/31/2023 | 745,981 | 60,303 | 64,984 | 113,396 | 13 |
12/31/2022 | 737,098 | 26,705 | -17,149 | 18,648 | N/A |
9/30/2022 | 752,500 | 32,233 | -8,913 | 30,329 | N/A |
6/30/2022 | 741,594 | 32,690 | 94,326 | 135,806 | N/A |
3/31/2022 | 756,226 | 47,954 | 77,123 | 117,590 | N/A |
12/31/2021 | 712,935 | 57,311 | 85,128 | 124,927 | N/A |
9/30/2021 | 691,250 | 62,508 | 80,215 | 123,618 | N/A |
6/30/2021 | 679,253 | 59,855 | 8,589 | 49,533 | N/A |
3/31/2021 | 645,942 | 42,119 | 35,709 | 73,853 | N/A |
12/31/2020 | 707,888 | 93,682 | 52,352 | 95,670 | N/A |
9/30/2020 | 713,400 | 120,571 | 77,080 | 112,990 | N/A |
6/30/2020 | 707,203 | 124,523 | 81,101 | 116,904 | N/A |
3/31/2020 | 695,621 | 121,767 | 52,556 | 102,782 | N/A |
12/31/2019 | 661,646 | 96,659 | 21,665 | 72,461 | N/A |
9/30/2019 | 631,974 | 57,725 | 12,273 | 62,240 | N/A |
6/30/2019 | 643,531 | 72,747 | 38,725 | 87,299 | N/A |
3/31/2019 | 642,834 | 63,386 | 76,092 | 103,714 | N/A |
12/31/2018 | 627,367 | 63,714 | 151,104 | 171,330 | N/A |
9/30/2018 | 625,106 | 65,679 | 167,298 | 186,973 | N/A |
6/30/2018 | 611,499 | 54,347 | 145,007 | 165,689 | N/A |
3/31/2018 | 600,054 | 51,845 | 124,916 | 149,649 | N/A |
12/31/2017 | 569,814 | 29,048 | 42,233 | 72,041 | N/A |
9/30/2017 | 554,276 | 30,269 | 33,537 | 61,644 | N/A |
6/30/2017 | 544,027 | 29,425 | 49,931 | 76,929 | N/A |
3/31/2017 | 539,097 | 39,358 | 55,850 | 75,851 | N/A |
12/31/2016 | 530,696 | 55,031 | 62,558 | 76,725 | N/A |
9/30/2016 | 542,313 | 71,812 | N/A | 78,627 | N/A |
6/30/2016 | 545,602 | 69,227 | N/A | 69,710 | N/A |
3/31/2016 | 547,922 | 54,933 | N/A | 95,617 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: EII0's forecast earnings growth (25.1% per year) is above the savings rate (0.2%).
Bénéfices vs marché: EII0's earnings (25.1% per year) are forecast to grow faster than the German market (10.2% per year).
Croissance élevée des bénéfices: EII0's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: EII0's revenue (9.1% per year) is forecast to grow faster than the German market (3.4% per year).
Croissance élevée des revenus: EII0's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if EII0's Return on Equity is forecast to be high in 3 years time